A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) death rate and recurrence rate have remained obstinately high. Current methods can not satisfy the need of predicting cancer relapse accurately. Utilizing expression profiles of 10 GEO datasets (N = 774), we identified 154 differentially expressed genes (DEGs)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Shi, Guodong, Zhang, Jingjing, Lu, Zipeng, Liu, Dongfang, Wu, Yang, Wu, Pengfei, Yin, Jie, Yuan, Hao, Zhu, Qicong, Chen, Lei, Fu, Yue, Peng, Yunpeng, Wang, Yan, Jiang, Kuirong, Miao, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762289/
https://ncbi.nlm.nih.gov/pubmed/29340021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados